⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2884597 | 0.74 | — | — | |
| SCHEMBL21147818 | 0.74 | CA1 (0.41) | — | |
| SCHEMBL19545969 | 0.74 | CA1 (0.41) | — | |
| SCHEMBL13865279 | 0.74 | CA1 (0.41) | — | |
| SCHEMBL26383024 | 0.74 | CA1 (0.41) | — | |
| SCHEMBL21147819 | 0.74 | CA1 (0.41) | — | |
| SCHEMBL844526 | 0.73 | — | — | |
| SCHEMBL12808170 | 0.73 | — | — | |
| SCHEMBL20713955 | 0.72 | — | — | |
| SCHEMBL359577 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11840521-B2 | Modulators of Mas-related G-protein receptor X4 and related products and methods | ESCIENT PHARMACEUTICALS, INC. (US) | 2023-12-12 | — | — | US | disclosed |
| US-11739269-B2 | Additive and application thereof | DAXIN MATERIALS CORPORATION (TW) | 2023-08-29 | — | — | US | disclosed |
| US-20230226035-A1 | SMALL MOLECULES AGAINST CEREBLON TO ENHANCE EFFECTOR T CELL FUNCTION | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2023-07-20 | — | — | US | disclosed |
| US-20230159474-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | INCYTE CORPORATION | 2023-05-25 | — | — | US | disclosed |
| WO-2023083343-A1 | POLYCYCLIC COMPOUNDS AND METHODS THEREOF | HEPAITECH (BEIJING) BIOPHARMA TECHNOLOGY CO., LTD. (CN) | 2023-05-19 | — | — | WO | disclosed |
| US-11643399-B2 | Modulators of mas-related G-protein receptor X4 and related products and methods | ESCIENT PHARMACEUTICALS, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| US-20210299285-A1 | COMPOUNDS USEFUL FOR IN VIVO IMAGING OF PROTEIN OXIDATION AND/OR CANCER TREATMENT | UNIV WAKE FOREST HEALTH SCIENCES (US) | 2021-09-30 | — | — | US | disclosed |
| US-10040838-B2 | CRHR2 peptide agonists and uses thereof | JANSSEN PHARMACEUTICA NV (BE) | 2018-08-07 | — | — | US | disclosed |
| US-20170326250-A1 | CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF | NOVARTIS AG (CH) | 2017-11-16 | — | — | US | disclosed |
| US-20170290878-A1 | METHODS OF TREATING CANCER WITH TUBULYSIN CONJUGATES | ENDOCYTE INC (US) | 2017-10-12 | — | — | US | disclosed |
| US-20080015151-A1 | CYANOVIRIN VARIANT-POLYMER CONJUGATES | THE GOVT. OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF (US) | 2008-01-17 | — | — | US | disclosed |
| US-20070287817-A1 | Mixture Composition Containing Unsaturated Carboxylic Acid and Alkene Ether Derivative Based Copolymers and Copolymers and Terpolymers Containing Sulfo Groups and Use Thereof | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2007-12-13 | — | — | US | disclosed |
| US-7232805-B2 | Cobalamin conjugates for anti-tumor therapy | INFLABLOC PHARMACEUTICALS, INC. (US) | 2007-06-19 | — | — | US | disclosed |
| EP-0906432-B1 | RECOMBINANT ALPHA-2,3-SIALYLTRANSFERASES AND THEIR USES | CA NAT RESEARCH COUNCIL (CA) | 2004-06-09 | — | — | EP | disclosed |
| US-6210933-B1 | AMINO ACID SEQUENCE; FOR ADDING SIALIC ACIDS TO GLYCOPROTEINS, GLYCOLIPIDS, AND OTHER ACCEPTOR MOLECULES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2001-04-03 | — | — | US | disclosed |
| US-6096529-A | FROM NEISSERIA SPECIES; FOR SYNTHESIS OF DESIRED OLIGOSACCHARIDES WITH BIOLOGICAL ACTIVITY | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2000-08-01 | — | — | US | disclosed |
| EP-0906432-A1 | RECOMBINANT ALPHA-2,3-SIALYLTRANSFERASES AND THEIR USES | National Research Council of Canada (CA) | 1999-04-07 | — | — | EP | disclosed |
| WO-1997047749-A1 | RECOMBINANT α-2,3-SIALYLTRANSFERASES AND THEIR USES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 1997-12-18 | — | — | WO | disclosed |
| US-4546104-A | Pyrazolopyridine cycloalkanones and process for their preparation | ICI AMERICAS INC. (US) | 1985-10-08 | — | — | US | disclosed |
| EP-0141608-A2 | Pyrazolopyridine cycloalkanone derivatives | ICI AMERICAS INC. (US) | 1985-05-15 | — | — | EP | disclosed |